Skip to contentS
Selectis Health, Inc.
S
GBCSSelectis Health, Inc. Q4 2019 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$2.05M$2.05Mderived+100.3% vs Q4 2018 Net Income-$1.04M-$1.04MderivedN/M vs Q4 2018 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Selectis Health, Inc. · CIK 727346 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Operating Incomederived-$113,492N/M Operating Cash Flowderived$113,810N/M Free Cash Flowderived$311,641N/M Margins · derivedOperating margin-5.5%+12.4 pt vs Q4 2018
Net margin-50.8%+35.5 pt vs Q4 2018
ended Dec 31, 2019 · filed Jul 10, 2020 · 192 d after period end